The U.S. Food and Drug Administration has approved a second round of non-mandatory vaccines to raise COVID-19 for anyone over the age of 50 who wants to have additional vaccinations.
The personnel clearance of Pfizer-BioNTech and Moderna comes as the new sub-variant of Omicron continues to spread rapidly overseas and raises concerns that it could lead to a similar increase in infections in the United States with cases of COVID-19. reduction in hospitals and deaths. United States in recent weeks.
The new sub-variant is BA.2 More contagious than the original omicron variant, which led to a record number of cases in the United States in January. However, it does not appear to be more severe in terms of the disease.
The second boost vaccine at this time is not recommended for everyone over 50 years of age.
but Application for Authorization for Second Boost Shot For people age 65 and older, Pfizer-BioNTech said the third dose of vaccine begins to expire symptoms of COVID-19 and prevent severe pain within three or more six months. Similarly, last month the Centers for Disease Control and Prevention discovered that booster injections expire after four months.
Pfizer also cited studies in Israel that found that corovirus infections were twice as common and serious illnesses were four times more common in people who received a second booster dose than those who received only of booster vaccine. .
Moderna Tells the FDA About It Permits Shots That “Offer Flexibility” to CDCs and Healthcare Professionals because It Means Healthcare Professionals Can Offer Additional Protection to the Individual Basis, “including those at high risk of COVID-19 due to age or accompanying diseases”.
Source: Huffpost
